Gempharmatech Co. Ltd. A (688046) — Working Capital to Net Assets Ratio
Gempharmatech Co. Ltd. A (688046) has a Working Capital to Net Assets ratio of 57.1% as of June 2025. Working capital of CN¥1.24 Billion (current assets of CN¥1.78 Billion minus current liabilities of CN¥543.76 Million) is measured against net assets of CN¥2.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Gempharmatech Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Gempharmatech Co. Ltd. A Working Capital to Net Assets (2019–2024)
This chart shows how Gempharmatech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 57.1%, reflecting working capital of CN¥1.24 Billion against net assets of CN¥2.17 Billion CNY. For the complete balance sheet picture, see how large is Gempharmatech Co. Ltd. A's balance sheet.
Annual Working Capital to Net Assets for Gempharmatech Co. Ltd. A (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Gempharmatech Co. Ltd. A from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Gempharmatech Co. Ltd. A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 62.7% | CN¥1.34 Billion | CN¥2.13 Billion | CN¥1.71 Billion | CN¥371.20 Million | ▲ +1.9 pp |
| 2023 | 60.8% | CN¥1.29 Billion | CN¥2.12 Billion | CN¥1.66 Billion | CN¥366.41 Million | ▼ -2.6 pp |
| 2022 | 63.4% | CN¥1.25 Billion | CN¥1.98 Billion | CN¥1.47 Billion | CN¥214.07 Million | ▼ -2.2 pp |
| 2021 | 65.6% | CN¥515.19 Million | CN¥785.63 Million | CN¥706.93 Million | CN¥191.74 Million | ▼ -10.2 pp |
| 2020 | 75.7% | CN¥497.78 Million | CN¥657.24 Million | CN¥647.25 Million | CN¥149.47 Million | ▼ -9.7 pp |
| 2019 | 85.5% | CN¥205.55 Million | CN¥240.47 Million | CN¥329.03 Million | CN¥123.48 Million | — |